News
NEWS
-
financingCelaid raised an additional 140 million yen from Kobe University Capital and Techno Science
-
financing
Celaid has raised 1.2 billion yen in its Series A financing round to advance HSC-based cell and gene therapies and platform
-
financingCelaid Therapeutics, developer of novel cell therapies, announces 500 million yen Series A financing.
-
financingCelaid was awarded a subsidy from BRI
-
financing
Capital procurement through third-party allotment of shares.